Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability.
about
Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularizationSelective alpha-particle mediated depletion of tumor vasculature with vascular normalizationAdhesion molecule expression and function of primary endothelial cells in benign and malignant tissues correlates with proliferationEndothelial progenitor cells: identity defined?Imaging and treating tumor vasculature with targeted radiolabeled carbon nanotubesVascular endothelial-cadherin tyrosine phosphorylation in angiogenic and quiescent adult tissuesThe human VE-cadherin promoter is subjected to organ-specific regulation and is activated in tumour angiogenesisp38 MAP kinase is necessary for melanoma-mediated regulation of VE-cadherin disassemblyInhibition of neovascularization to simultaneously ameliorate graft-vs-host disease and decrease tumor growthVEGFR-2 expression in carcinoid cancer cells and its role in tumor growth and metastasis.Combretastatin A4 phosphate induces rapid regression of tumor neovessels and growth through interference with vascular endothelial-cadherin signaling.VE-cadherin expression and clustering maintain low levels of survivin in endothelial cells.Suppression of retinal neovascularization with an antagonist to vascular endothelial cadherin.Mechanism of Collaborative Enhancement of Binding of Paired Antibodies to Distinct Epitopes of Platelet Endothelial Cell Adhesion Molecule-1.Anti-apoptosis effects of vascular endothelial cadherin in experimental corneal neovascularization.Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasisNascent endothelium initiates Th2 polarization of asthma.Antiangiogenic therapy in brain tumors.Vascular Targeted Radioimmunotherapy for the Treatment of Glioblastoma.Blood-based biomarkers for the optimization of anti-angiogenic therapiesMechanisms and targets for angiogenic therapy after stroke.Tumor angiogenesis: insights and innovations.Endothelial cell-to-cell junctions: adhesion and signaling in physiology and pathology.Clinical use of TNF revisited: improving penetration of anti-cancer agents by increasing vascular permeability.Inhibition of B16 melanoma growth and metastasis in C57BL mice by vaccination with a syngeneic endothelial cell line.Adrenomedullin blockade induces regression of tumor neovessels through interference with vascular endothelial-cadherin signalling.Antitumor immunity induced by VE-cadherin modified DC vaccine.Wnt signaling mediates pathological vascular growth in proliferative retinopathyEpithelial protein lost in neoplasm (EPLIN) interacts with α-catenin and actin filaments in endothelial cells and stabilizes vascular capillary network in vitro.Vascular endothelial effects of collaborative binding to platelet/endothelial cell adhesion molecule-1 (PECAM-1).
P2860
Q24673319-80FA2583-1020-41D7-BCFF-D61512FC449AQ27303072-AFB59730-48A6-401B-B2D0-4B828AB81BF3Q27315862-49BC9C1F-98ED-4901-A983-89DBCD4F22FAQ28303395-98E1DEA7-25F4-442B-8602-44DC1D94301CQ28384090-1DB9D3AA-DA74-4B8C-9B62-7BB5582402D1Q33556970-40DD6F5D-2A2F-4320-AA8F-959CB2D3DAB5Q33568457-1EA7E80D-1326-4280-8B9F-D9BC853B6D77Q33840402-4B58E8FD-058D-48B1-AECB-AC9595BD6ED8Q33915046-B94F7BC4-250A-489E-831A-8DD4DA1CD0E0Q33926020-5F2DF670-8BA8-484D-98B3-AF4A9400D098Q34078666-C1480995-D114-4811-AA34-A4BA12C3FEC5Q35102828-9D8A773B-6B36-4249-AAE1-DFD1FDF22620Q35606197-A5620592-6192-49D4-AD67-832F556E1E52Q36248811-B1BDA4CC-0E3E-4FF3-AE93-C834A8C0D292Q36296985-510DC303-F471-413C-8341-6FA4D58B4399Q36322698-90AF95B2-D325-4269-BF85-1EC3C3888AE9Q36717794-79A68BDD-754C-4B04-B481-D4544F07A18BQ37129915-3675AA32-72D1-48D2-B5EE-0D0F2503C29CQ37309920-C4C96CBF-28E8-4D24-AE7E-7FD7E0C3112FQ37328390-462472DA-FD46-4C33-9651-831B0AC79072Q37442498-32A6460A-0B8C-4468-937C-C3230F986D78Q37743207-14C9CF7E-58DE-4AC4-9168-E1B6A4723175Q38048760-320D8C67-0454-4D14-B986-2E419F8E200EQ39735980-676E5B27-B784-4406-BB00-875C67DE59B0Q39888963-C2D717AF-3E95-459C-99D2-4D4E34F2EA12Q40998530-F2895BC9-639A-4CE2-8078-A54275F240FAQ42366549-FF93A208-3C2E-4095-8FEF-791AF2F56528Q42546329-C7D12D01-1698-404C-8106-125BEC2612CDQ42605259-83DC1A07-0E1C-4E83-B031-9D169AD297E3Q48171757-BCDD5F3F-426F-4E30-8E3C-40C5F863718F
P2860
Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Selective targeting of angioge ...... fecting vascular permeability.
@en
Selective targeting of angioge ...... fecting vascular permeability.
@nl
type
label
Selective targeting of angioge ...... fecting vascular permeability.
@en
Selective targeting of angioge ...... fecting vascular permeability.
@nl
prefLabel
Selective targeting of angioge ...... fecting vascular permeability.
@en
Selective targeting of angioge ...... fecting vascular permeability.
@nl
P2093
P1433
P1476
Selective targeting of angioge ...... fecting vascular permeability.
@en
P2093
Bridget Finnerty
Daniel J Hicklin
Jacqueline F Doody
Jay Overholser
Paul Kussie
Peter Bohlen
Rajiv Bassi
P304
P407
P577
2002-05-01T00:00:00Z